Medicine & Life Sciences
3-hydroxy-3-methylglutaryl-coenzyme A
12%
Cardiovascular Diseases
7%
Central Nervous System
51%
Cognition
7%
Cognition Disorders
15%
Depression
6%
Dyslipidemias
9%
Epilepsy
8%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
67%
Multiple Sclerosis
8%
Myocardial Infarction
7%
Neoplasms
3%
Nervous System Diseases
18%
Neurodegenerative Diseases
8%
Oxidoreductases
9%
Pharmacokinetics
7%
Pharmacology
6%
Primary Prevention
10%
Secondary Prevention
9%
Stroke
13%
Therapeutics
1%
Physics & Astronomy
cancer
12%
central nervous system
97%
coenzymes
22%
cognition
20%
disorders
21%
epilepsy
20%
inhibitors
16%
strokes
46%
Engineering & Materials Science
Coenzymes
43%
Neurodegenerative diseases
34%
Neurology
81%
Oxidoreductases
34%
Pharmacokinetics
32%
Chemical Compounds
Coenzyme A
14%
Disorder
19%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Neurological Effect
21%
Pharmacokinetics
8%
Pharmacological Effect
14%